PPT: Natural Killer Cells Therapeutics Market to Witness Huge Growth during 2021-2026.

Global Natural Killer Cells Therapeutics Market and Upcoming Forecast Report © 2019 IMARC All Rights Reserved

Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group

About IMARC Group

Report Description

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regionThe s to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights Report Description Global Natural Killer Cells Therapeutics Market Outlook 2026:

According to IMARC Group’s latest report, titled “Natural Killer Cells Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global natural killer cells therapeutics market exhibited strong growth during 2015-2020.

Natural killer (NK) cells are large granular lymphocytes responsible for producing immunoregulatory cytokines. They are a type of white blood cells that act as a vital component of the human immune system.

They contain small granules of special proteins such as proteases and perforin known as granzymes. NK cell therapeutics are developed through ex vivo pre-conditioning with cytokine or small molecular drugs and chimeric antigen receptor (CAR) NK. They aim at pathogenic antigens with cytotoxicity and reduce the risk of cytokine storms.

Request for a PDF sample of this report: https://www.imarcgroup.com/natural-killer-cells-therapeutics-market/requestsample

Report Description and Highlights

Report Description

Natural Killer Cells Therapeutics Market Trends:

A significant rise in the number of individuals with cancer, infectious diseases, and liver disorders represents one of the primary factors fueling the market growth. This can be attributed to unhealthy dietary patterns, lack of physical activities, growing air pollution, and the increasing number of individuals consuming alcohol and tobacco products.

Moreover, as the risk of developing cancer rises dramatically with age, the increasing geriatric population across the globe is acting as another growth-inducing factor catalyzing the demand for NK cells therapeutics.

Apart from this, as the immune response of cancer patients is not adequate, health companies are developing novel methods and technologies to boost the immune response through allogeneic, off-theshelf NK cell-based therapies.

Furthermore, there is a rise in the number of clinical studies that focus on tumor-targeted antibody strategies to enhance the therapeutic benefit of NK-cell-based therapy while minimizing risks and toxicities.

Report Description and Highlights

Report Description

In addition, governing agencies of numerous countries are funding financial schemes for cancer patients, which is creating a favorable outlook for the market.

Looking forward, IMARC Group expects the market to grow at a CAGR of around 15% during 20212026.

Report Description and Highlights

Report Description Key Market Segmentation: Breakup by Therapeutics: •NK Cell Therapies •NK Cell Directed Antibodies

Breakup by Application:

•Cancer •Gastrointestinal Diseases •Immuno proliferative Disorders •Others

Breakup by End User:

•Hospitals •Research Centers and Institutes •Others

Report Description and Highlights

Report Description Breakup by Region: •North America • United States • Canada •Asia-Pacific • China • Japan • India • South Korea • Australia • Indonesia •Europe • Germany • France • United Kingdom • Italy • Spain • Russia •Latin America • Brazil • Mexico •Middle East and Africa

Report Description and Highlights

Report Description Competitive Landscape:

•Affimed GmbH •Bristol-Myers Squibb Company •Fate Therapeutics •Fortress Biotech Inc. •Glycostem Therapeutics •Innate Pharma S.A. •Kuur Therapeutics Inc •Athenex Inc •Nkarta Inc. •Takeda Pharmaceutical Company Limited •Ziopharm Oncology Inc. •.

Note: We are updating our research report 2021-2026. If you want to need latest primary and secondary data with Cost Module, Business Strategy, Distribution Channel, etc View Report TOC, Figures and Tables: https:// www.imarcgroup.com/natural-killer-cells-therapeutics-market

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

Report Description and Highlights

Report Description

© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Contact Us

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com